ChartRow logo
ChartRow
Investing Charts
ABT
Abbott LaboratoriesStock · HealthcareS&P 500 0.3%
$103.11+$2.36 (+2.34%)as of market close, Jul 24, 2026
CompareLLYUNHJNJABBVISRGMRK

ABTAbbott Laboratories stock price, chart and key statistics

Key stats

Price data

Price
$103.11
Change YTD
-16.97%
Market cap
179.6B
Enterprise value
202.4B
Shares outstanding
1.7B
52W low
$81.97
52W high
$137.49
From 52W high
-25.01%
From 52W low
+25.79%
52W range
38%
Beta
0.61

Volume

Rel volume
1.07×
30D volume
14M
30D $ vol
1.3B

Fundamentals

Sales (ttm)
45.1B
Sales/share
$25.91
EPS (ttm)
$3.59
FCF (ttm)
7.4B
FCF/share
$4.24
Book value/share
$29.89
Net margin
13.91%
ROE
12.06%
ROA
5.68%
Debt / equity
0.57×
Current ratio
1.39

Growth (CAGR, ttm) · 10Y

Sales
+8.27%
Net income
+9.88%
FCF
+15.46%
Shares
+1.72%

Per-share growth (CAGR, ttm) · 10Y

EPS
+8.29%
Sales/share
+6.44%
FCF/share
+13.51%
Book value/share
+7.80%
Dividend/share
n/a
Price
+9.09%
Total return
+11.08%

Fundamentals end at the last reported quarter; price and total return end at the latest close.

Valuation

P/E (ttm)
28.6×
Fwd P/E
16.5×
P/S (ttm)
4.0×
P/B (mrq)
3.4×
P/FCF (ttm)
24.3×
EV/EBITDA (fy)
21.3×
EV/Sales (ttm)
4.5×
FCF yield (ttm)
4.11%
Dividend yield (fwd)
2.44%
Dividend/share (fwd)
$2.52
Buyback yield (ttm)
0.44%
Shareholder yield (ttm)
2.77%

Vs own 10Y history

P/E
25th
P/S
27th
P/B
19th
P/FCF
21st

Bar = where today's multiple sits in ABT's own 10-year range:near a decade-low (cheap)near a decade-high (rich).

Performance

1D
+2.34%
1W
+2.41%
1M
+13.95%
3M
+11.49%
YTD
-16.97%
1Y
-18.06%
5Y
-12.25%

Financial statements

Open full ABT financials →

Related Healthcare

1M
TickerThemePrice1M30D $Vol
LLY
Eli Lilly and Company
Pharmaceuticals$1,196+7.05%3.2B
JNJ
Johnson & Johnson
Pharmaceuticals$263+9.30%2.1B
ABBV
AbbVie Inc.
Biopharma$259+10.36%1.9B
UNH
UnitedHealth Group Incorporated Common Stock (DE)
$421+3.66%2.6B
MRK
Merck & Co. Inc.
Pharmaceuticals$131+8.70%1.3B
TMO
Thermo Fisher Scientific Inc.
Life Sciences$568+15.45%1.1B
AMGN
Amgen Inc.
Biotech$376+7.00%969.4M
GILD
Gilead Sciences Inc.
Biotech$129+3.32%976.5M

Abbott Laboratories (ABT) trades at $103.11 with a live price and an interactive chart covering 43+ years of daily price history, plus key valuation metrics. ChartRow also publishes ABT's financial statements free — annual and quarterly income statement, balance sheet, and cash flow straight from SEC filings, with P/E and valuation history and dividend data. See full ABT financial statements →